$LXRX 3 SEC Filings

Filed On	Filing
12 Feb 2026	Form 3: Avicenna Life Sci Master Fund Lp, Director and 1 other Holds 1,538,462 shares of Common Stock
09 Jun 2025	Form 3: Gopinathan Suma, SVP, Discovery Holds 74,520 shares of Common Stock
06 Jun 2025	Form 3: Martens Rachel Yap, VP, Partnerships & Corp Strat Holds 0 shares of Common Stock
02 Jan 2025	Form 3: Coiante Scott M, SVP, Chief Financial Officer
16 Dec 2024	Form 3: Artal Participations S.a r.l., Director Holds 136,180,481 shares of Common Stock
02 Dec 2024	Form 3: Cheung Ivan, Director No securities owned
07 Oct 2024	Form 3: DeFrancesco Lisa, VP, IR and Corp Strategy Holds 0 shares of Common Stock
12 Aug 2024	Form 3: Corrigan Brian, SVP, Regulatory & QA No securities owned
29 Jul 2024	Form 3: Siren, L.l.c., Director and 1 other Holds 3,516,214 shares of Common Stock
08 Jul 2024	Form 3: Exton Michael, Director No securities owned
11 Oct 2023	Form 3: Garner Thomas, SVP, Chief Commercial Officer No securities owned
31 Jul 2023	Form 3: Sullivan Diane E., Director No securities owned
04 Jan 2022	Form 3: McDermott Wendy, VP, Human Resources No securities owned
29 Oct 2021	Form 3: Seth Kiernan, VP, Chief Commercial Officer
01 Oct 2021	Form 3: Kassler-Taub Kenneth B., SVP, Regulatory & QA Holds 62,470 shares of Common Stock
27 Sep 2021	Form 3: Alexander Kristen, VP, Finance and Accounting Holds 9,000 shares of Common Stock
03 Aug 2021	Form 3: Granowitz Craig B, SVP, Chief Medical Officer No securities owned
21 Jan 2021	Form 3: Wittouck Amaury, Director Holds 32,259,461 shares of Common Stock
11 Jan 2021	Form 3: Invus Partners, Llc, Director Holds 4,321,214 shares of Common Stock
04 Nov 2019	Form 3: Crum Brian T, VP, General Counsel & Secr. Holds 22,925 shares of Common Stock

Comments